Strengthening R&D investment, primarily in environmental and safety-related fields
First written in FY2016. 20 of 38 entries say "Restated". Latest entry: 2026-07-31.
54 other companies' latest entry also says "Advanced".
- 2026-07-31AdvancedEarnings
「Although operating profit benefited from the depreciation of the yen, it was ¥84.2 billion, down ¥23.0 billion, or 21.5%, from the same quarter of the previous year, owing to higher material costs and other factors and increased investment for future growth.」
The strengthened investment for future growth is specifically identified as a factor reducing operating profit. - FY2026AdvancedAnnual report
「Group-wide R&D expenses for the fiscal year were ¥690,073 million, including capitalized costs, comprising ¥608,205 million in the Japan segment, ¥31,658 million in the North America segment, ¥14,120 million in the Europe segment, ¥34,867 million in the Asia segment and ¥1,223 million in Other.」
R&D expenses increased from ¥619,404 million to ¥690,073 million. Under the three pillars of CORE 2030, the company is expanding its development areas to electrification and SiC, AI-driven development, smart factories, agriculture and semiconductors, among others. - 2026-05-23AdvancedGeneral Meetings of Shareholders
「While accelerating investment for future growth, including capital expenditure to achieve innovative manufacturing and research and development expenses in intelligent systems, our earnings power improved through increased sales of our priority electrification and intelligent systems products.」
Research and development expenses increased from ¥619,404 million to ¥690,073 million, expanding investment in future growth, including the intelligent systems field. - FY2026-H1Update to first-half R&D expensesAnnual report
「R&D expenses for the interim consolidated period were ¥347,726 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the interim consolidated period.」
R&D expenses for the interim period were ¥347,726 million. The company explained that there were no significant changes in the status of R&D activities. - FY2025AdvancedAnnual report
「Group-wide R&D expenses for the fiscal year were ¥619,404 million, including capitalized costs, comprising ¥537,824 million in the Japan segment, ¥31,636 million in the North America segment, ¥16,498 million in the Europe segment, ¥32,375 million in the Asia segment and ¥1,071 million in Other. The Japan segment accounted for approximately 87% and was the core of R&D activities.」
R&D expenses increased from ¥550,921 million in the previous fiscal year to ¥619,404 million, while the company expanded its development areas to electrification, the circular economy, semiconductors, software, hydrogen, food and agriculture, among others. - FY2025-H1Update to first-half R&D expensesAnnual report
「R&D expenses for the interim consolidated period were ¥301,632 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the interim consolidated period.」
First-half R&D expenses of ¥301,632 million were disclosed, and the company explained that there were no significant changes in the status of R&D activities. - FY2024Full-Year R&D Expense UpdateAnnual report
「Group-wide R&D expenses for the fiscal year were ¥550,921 million, including capitalized costs, comprising ¥485,438 million in the Japan segment, ¥32,021 million in the North America segment, ¥14,642 million in the Europe segment, ¥17,771 million in the Asia segment and ¥1,049 million in Other.」
Updated full-year R&D expenses to ¥550,921 million. The Japan segment accounted for approximately 88% and continued to be the core of R&D activities. - FY2024-Q3Update to cumulative R&D expenses for the first nine monthsAnnual report
「R&D expenses for the first nine months of the fiscal year were ¥403,859 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first nine months.」
R&D expenses of ¥403,859 million for the first nine months were disclosed, and the company explained that there were no significant changes in the status of R&D activities. - FY2024-Q2Update to cumulative R&D expenses for the first six monthsAnnual report
「R&D expenses for the first six months of the fiscal year were ¥266,283 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first six months.」
R&D expenses were ¥266,283 million, while the company explained that there were no significant changes in the status of R&D activities. - FY2024-Q1First-quarter R&D expenses updatedAnnual report
「R&D expenses for the first quarter were ¥132,837 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first quarter.」
First-quarter R&D expenses of ¥132,837 million were disclosed, and the company explained that there were no significant changes in the status of R&D activities. - FY2023Full-Year R&D Expense UpdateAnnual report
「Group-wide R&D expenses for the fiscal year were ¥521,615 million, including capitalized costs, comprising ¥461,264 million in the Japan segment, ¥29,602 million in the North America segment, ¥13,432 million in the Europe segment, ¥16,267 million in the Asia segment and ¥1,050 million in Other. The Japan segment accounted for approximately 88% and was the core of R&D activities.」
Updated full-year R&D expenses to ¥521,615 million and the Japan segment ratio to approximately 88%. - FY2023-Q3RestatedAnnual report
「R&D expenses for the first nine months of the fiscal year were ¥385,629 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first nine months.」
R&D expenses for the first nine months of the fiscal year were ¥385,629 million, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2023-Q2RestatedAnnual report
「R&D expenses for the first six months of the fiscal year were ¥258,840 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first six months.」
R&D expenses for the first six months of the fiscal year were ¥258,840 million, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2023-Q1RestatedAnnual report
「R&D expenses for the first quarter were ¥127,390 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first quarter.」
First-quarter R&D expenses of ¥127,390 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2022Full-Year R&D Expense UpdateAnnual report
「Group-wide R&D expenses for the fiscal year were ¥497,556 million, including capitalized costs, comprising ¥444,467 million in the Japan segment, ¥26,179 million in the North America segment, ¥11,270 million in the Europe segment, ¥14,804 million in the Asia segment and ¥836 million in Other. The Japan segment accounted for approximately 89% and was the core of R&D activities.」
Updated full-year R&D expenses of ¥497,556 million and the Japan segment's approximately 89% share. - FY2022-Q3RestatedAnnual report
「R&D expenses for the first nine months of the fiscal year were ¥364,288 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first nine months.」
R&D expenses of ¥364,288 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2022-Q2RestatedAnnual report
「R&D expenses for the first six months of the fiscal year were ¥240,877 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first six months.」
R&D expenses for the first six months of the fiscal year were ¥240,877 million, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2022-Q1RestatedAnnual report
「R&D expenses for the first quarter were ¥120,205 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first quarter.」
First-quarter R&D expenses of ¥120,205 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2021Full-Year R&D Expense UpdateAnnual report
「Group-wide R&D expenses for the fiscal year were ¥492,012 million, including capitalized costs, comprising ¥440,580 million in the Japan segment, ¥27,347 million in the North America segment, ¥10,839 million in the Europe segment, ¥12,662 million in the Asia segment and ¥584 million in Other. The Japan segment accounted for approximately 90% and was the core of R&D activities.」
Updated FY2021 R&D expenses of ¥492,012 million and the R&D structure in which the Japan segment accounted for approximately 90%. - FY2021-Q3RestatedAnnual report
「R&D expenses for the first nine months of the fiscal year were ¥362,715 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first nine months.」
R&D expenses of ¥362,715 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2021-Q2RestatedAnnual report
「R&D expenses for the first six months of the fiscal year were ¥243,754 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first six months.」
R&D expenses of ¥243,754 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2020AdvancedAnnual report
「Group-wide R&D expenses for the fiscal year were ¥507,827 million, including capitalized costs, comprising ¥450,096 million in the Japan segment, ¥30,380 million in the North America segment, ¥12,467 million in the Europe segment, ¥14,013 million in the Asia segment and ¥871 million in Other. The Japan segment accounted for approximately 89% and was the core of R&D activities.」
R&D expenses increased to ¥507,827 million, and the company disclosed a structure in which the Japan segment accounted for approximately 89%. - FY2020-Q3RestatedAnnual report
「R&D expenses for the first nine months of the fiscal year were ¥376,620 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first nine months.」
R&D expenses of ¥376,620 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2020-Q2RestatedAnnual report
「R&D expenses for the first six months of the fiscal year were ¥252,495 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first six months.」
R&D expenses of ¥252,495 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2020-Q1RestatedAnnual report
「R&D expenses for the first quarter were ¥125,253 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first quarter.」
R&D expenses of ¥125,253 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2019AdvancedAnnual report
「As vehicle electrification has progressed rapidly worldwide in recent years and global demand for electrification products has increased, the group will invest approximately ¥180.0 billion over the three years from fiscal 2018 through the end of fiscal 2020 to further strengthen its development and production structure.」
The company indicated plans to invest approximately ¥180.0 billion over the three years from fiscal 2018 through the end of fiscal 2020 to strengthen its development and production structure for electrification products. - FY2019-Q3RestatedAnnual report
「R&D expenses for the first nine months of the fiscal year were ¥368,399 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first nine months.」
R&D expenses of ¥368,399 million were recorded, and the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2019-Q2RestatedAnnual report
「R&D expenses for the first six months of the fiscal year were ¥245,147 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first six months.」
R&D expenses of ¥245,147 million were recorded, while the company stated that there were no significant changes in the status of R&D activities. - FY2019-Q1RestatedAnnual report
「Operating profit was ¥90.9 billion, down ¥2.3 billion, or 2.4%, from the same quarter of the previous year, as accelerated investment in future competitive areas outweighed gains from operating leverage and streamlining efforts. R&D expenses for the first quarter were ¥118,198 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first quarter.」
While accelerated investment in future competitive areas was identified as a factor behind the decline in operating profit, the company reaffirmed that there were no significant changes in the status of R&D activities. - FY2018AdvancedAnnual report
「Group-wide R&D expenses for the fiscal year were ¥447,378 million, including capitalized costs, comprising ¥395,053 million in the Japan segment, ¥26,838 million in the North America segment, ¥12,271 million in the Europe segment, ¥12,108 million in the Asia segment and ¥1,108 million in Other. The Japan segment accounted for approximately 88% and was the core of R&D activities.」
R&D expenses increased to ¥447,378 million. The company also described advanced R&D centers and activities in Tokyo and Israel. The Japan segment was identified as the core of R&D. - FY2018-Q3RestatedAnnual report
「R&D expenses for the first nine months of the fiscal year were ¥314,098 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first nine months.」
R&D expenses of ¥314,098 million were recorded, while the company stated that there were no significant changes in the status of R&D activities. - FY2018-Q2RestatedAnnual report
「R&D expenses for the first six months of the fiscal year were ¥201,356 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first six months.」
R&D expenses of ¥201,356 million were recorded, while the company stated that there were no significant changes in the status of R&D activities. - FY2018-Q1RestatedAnnual report
「R&D expenses for the first quarter were ¥99,710 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first quarter.」
R&D expenses of ¥99,710 million were recorded, and the company stated that there were no significant changes in the status of R&D activities. - FY2017AdvancedAnnual report
「Group-wide R&D expenses for the fiscal year were ¥409,223 million, including capitalized costs, comprising ¥344,459 million in the Japan segment, ¥31,124 million in the North America segment, ¥13,739 million in the Europe segment, ¥18,702 million in the Asia segment and ¥1,199 million in Other. The Japan segment accounted for approximately 84% and was the core of R&D activities, but the company aims to realize a globally advanced mobility society by strengthening research functions in overseas segments and through other initiatives.」
R&D expenses were ¥409,223 million, and the company continued to highlight efforts to strengthen research functions in overseas segments. - FY2017-Q3RestatedAnnual report
「R&D expenses for the first nine months of the fiscal year were ¥304,021 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first nine months.」
R&D expenses of ¥304,021 million were recorded, while the company stated that there were no significant changes in the status of R&D activities. - FY2017-Q2RestatedAnnual report
「R&D expenses for the first six months of the fiscal year were ¥199,411 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first six months.」
R&D expenses of ¥199,411 million were recorded, while the company stated that there were no significant changes in the status of R&D activities. - FY2017-Q1RestatedAnnual report
「Japan recorded lower profit of ¥14.2 billion, down ¥29.1 billion, or 67.3%, from the same quarter of the previous year, due to the foreign-exchange impact on overseas exports and increased expenses for future growth, including R&D expenses. R&D expenses for the first quarter were ¥95,566 million, including capitalized costs. There were no significant changes in the status of R&D activities by the consolidated companies during the first quarter.」
R&D expenses of ¥95,566 million were recorded, and the company explained the increase in expenses aimed at future growth, while stating that there were no significant changes in the status of R&D activities. - FY2016First statedAnnual report
「We aim to strengthen R&D activities, primarily in the fields of the environment, safety and security, and to contribute to society by delivering new products and new value to customers worldwide. Group-wide R&D expenses for the fiscal year were ¥399,238 million, including capitalized costs. Overseas segments currently account for approximately 16% of R&D expenses, but we plan to increase this ratio by establishing an enhanced development structure.」
R&D expenses were ¥399,238 million, with overseas operations accounting for approximately 16%; the company stated its policy of increasing the overseas development ratio.